Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
MWN-AI** Summary
Surgery Partners, Inc. (NASDAQ:SGRY), a prominent player in the short-stay surgical facility sector, has announced its upcoming fourth quarter 2025 earnings release, set for after market close on March 2, 2026. The company will hold a conference call on March 3, 2026, at 8:30 a.m. Eastern Time to discuss these results in detail. Participants can access the call via phone, with domestic callers using 1-877-451-6152 and international callers using 1-201-389-0879. A replay of the call will be available three hours post-call until March 17, 2026, with the same passcode (13758530) applicable for both live and replay access.
Those interested can also join the conference call through a live webcast, which will be available in the Investor Relations section of Surgery Partners' website at www.surgerypartners.com. The company emphasizes its website as a crucial platform for distributing company information and keeping investors informed about financial updates and other significant material.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company specializing in a differentiated outpatient delivery model. Its focus is on providing high-quality, cost-effective surgical and ancillary care, benefiting patients and physicians alike. With over 200 locations across 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities, Surgery Partners has established itself as one of the fastest-growing surgical services businesses in the United States. For more details about the company and its services, interested parties are encouraged to visit their website.
MWN-AI** Analysis
As Surgery Partners, Inc. (NASDAQ: SGRY) prepares to announce its fourth-quarter 2025 earnings on March 2, 2026, investors should consider several factors that could influence the company's stock performance moving forward. The earnings report may provide crucial insights into the company’s growth trajectory, especially within the context of the ongoing transformation in healthcare delivery.
With the industry increasingly shifting toward outpatient care and cost-effective solutions, Surgery Partners is well-positioned to capitalize on this trend. Their model focuses on providing high-quality surgical services in a more efficient, outpatient setting, which can lead to reduced costs for both patients and payers. This positions the company favorably in comparison to traditional hospital services, especially as value-based care continues to evolve.
Investors should pay attention to key performance indicators that will likely be highlighted in the earnings call, such as patient volumes, revenue growth, and margins, particularly in light of inflationary pressures that have affected operational costs across the healthcare sector. The management’s commentary during the conference call can provide vital context regarding future strategies and growth initiatives—especially concerning expansion plans and potential mergers or acquisitions, which could further solidify their market position.
Moreover, analysts will be keen to evaluate the integration of new facilities and technologies that enhance patient care, as well as any updates on partnerships with payers that may influence reimbursement rates.
In summary, as the earnings date approaches, investors should prepare for potential volatility based on the results and guidance provided. Monitoring the conference call closely will be essential to gauge the company’s outlook and to assess how well it is navigating the complexities of the healthcare landscape. As always, diversification and careful analysis are key to making informed investment decisions in this dynamic sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time).
You can join the call as follows:
- Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)
- Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)
- Passcode for the live call and the replay: 13758530
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.
To learn more about Surgery Partners, please visit the company's website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution of material company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company's website and is readily accessible.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.
Contact:
Surgery Partners Investor Relations
(615) 234-8940
IR@surgerypartners.com
FAQ**
What key financial metrics will Surgery Partners Inc. SGRY focus on during the Q4 2025 earnings call on March 3, 2026, and how do they compare with previous quarters?
What factors contributed to the growth of Surgery Partners Inc. SGRY in the last quarter, and how does the company plan to sustain this momentum moving forward?
How does Surgery Partners Inc. SGRY's outpatient delivery model differentiate it from competitors in the surgical services industry, and what advantages does this provide?
What insights or guidance can investors expect from Surgery Partners Inc. SGRY regarding its strategic initiatives and market outlook for 2026 during the upcoming conference call?
**MWN-AI FAQ is based on asking OpenAI questions about Surgery Partners Inc. (NASDAQ: SGRY).
NASDAQ: SGRY
SGRY Trading
-2.26% G/L:
$13.63 Last:
879,770 Volume:
$13.70 Open:



